No Data
Profit: 2024 Annual Results Forecast
VTR Bio-Tech to Redeem Convertible Bonds of 665 Million Yuan
Guangdong Vtr Bio-Tech (300381.SZ): Jindadi Investment has cumulatively reduced its shareholding by 1.94%.
On December 15, Gelonghui reported that Guangdong Vtr Bio-Tech (300381.SZ) announced that on December 13, 2024, the company received a notice from Jinda Di Investment regarding the completion of the shareholding reduction plan. On December 12, 2024, Jinda Di Investment reduced its shareholding by 720,000 shares through a block trade, accounting for 0.15% of the company's total share capital after deducting shares held in the company's repurchase special securities account. As of the date of this announcement, Jinda Di Investment has cumulatively reduced its shareholding by 9,309,000 shares, accounting for 1.94% of the company's total share capital after deducting shares held in the company's repurchase special securities account.
Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Largest Shareholders Are Retail Investors Who Were Rewarded as Market Cap Surged CN¥398m Last Week
Profit: Report for the third quarter of 2024
Guangdong VTR Bio-Tech (300381.SZ) released its performance for the first three quarters, with a net income of 42.7988 million yuan, an increase of 245.33%.
Guangdong VTR Bio-Tech (300381.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved a revenue of 6...
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Not Doing Enough For Some Investors As Its Shares Slump 27%